Vaccinations for Hepatitis A and B

Candidates for Hepatitis A Vaccination

Routine Vaccination

  • Children living in areas with high incidence rates of hepatitis A.
  • High-Risk Populations
  • Travelers to developing countries with high rates of hepatitis A, including Mexico
  • Men who have sex with men
  • Users of illegal drugs
  • People who work with hepatitis A virus in research settings
  • People who work with infected nonhuman primates
  • Recipients of clotting factor concentrates
  • People with chronic liver disease (because of risk of fulminant hepatitis A)

Candidates for Hepatitis B Vaccination

  • All infants, children, and adolescents
  • High-Risk Populations
  • People with multiple sex partners and those who have been recently diagnosed with a sexually transmitted disease
  • Sex partners and household contacts of HBV carriers
  • Men who have sex with men
  • Household contacts of adoptees from countries with high rates of hepatitis B
  • Injection drug users
  • Travelers to countries with high rates of hepatitis B (staying longer than 6 months)
  • People with occupational exposure to blood
  • Clients and staff in institutions for the developmentally disabled
  • Patients with chronic kidney failure (including those on chronic hemodialysis)
  • Patients receiving clotting factor concentrates
  • Inmates of long-term correctional facilities

Postexposure Prophylaxis

Prophylactic treatment for exposure to hepatitis B virus involves either hepatitis B immune globulin (HBIG), hepatitis B vaccine, or a combination of both. The HBIG dose equals 0.06 mL/kg. Efficacy ranges from 70 to 95 percent for different types of exposure.




1 dose of HBIG given with the first hepatitis B vaccine dose.

Percutaneous or permucosal

HBIG and vaccination depending on vaccination and exposure status.


HBIG with or without vaccination for exposure to acute hepatitis B; vaccination alone for chronic exposure.

Household contact

HBIG with vaccination for acute hepatitis B in infants under age 12 months; vaccination alone for chronic.

Combination Vaccine

There are combination vaccines available that combine vaccinations for hepatitis A and B Los Angeles in one injection. It protects individuals 18 years of age or older against diseases caused by hepatitis A and hepatitis B viruses. The vaccine is recommended for travelers whose occupation or behavior puts them at high risk for exposure to hepatitis B virus, or who are visiting countries with a high or intermediate rate of both hepatitis viruses, as defined by the Centers for Disease Control and Prevention.

Get your
Consultation Today!
Siamak Tabib, M.D., Inc.
8631 West Third Street
Suite 1015E
Los Angeles, CA 90048
(310) 652-4472
(310) 358-2266 (Fax)